Skip to content

Calculus Capital invests in Arcis Biotechnology

Calculus Capital announces today that it has invested £1.25m in Arcis. This investment is part of a larger fundraising of £1.7m and follows previous investments in Arcis totalling £2m made in May 2012 and June 2013. Based in Cheshire, Arcis develops patented compounds and technologies. It then commercialises these novel technologies and application methods to … Continued

Calculus Capital invests in WheelRight

Private equity fund manager Calculus Capital invests £2.5m in WheelRight Ltd, a tyre monitoring company. WheelRight develops and sells advanced remote tyre monitoring equipment, which accurately measures the pressure within a vehicle’s tyres when the vehicle is driven over a sensor plate. This system, which is effective regardless of vehicle or tyre type, provides fleet … Continued

Calculus Capital goes for the double

Calculus Capital has notched up two deals, investing £1.25m in R&D company Arcis and £2.5m in WheelRight, a tyre monitoring company. Arcis develops patented compounds and technologies related to DNA extraction and molecular diagnostics, and pesticides used for agriculture. It then licenses these products to commercial partners. WheelRight, whose client list includes Stagecoach, sells remote … Continued

Calculus Capital invests in Premaitha

Calculus Capital has invested approximately £1m in Premaitha Health. This investment is part of a larger fundraising of £7.25 million and subsequent admission to trading on London Stock Exchange’s junior market for growth companies, AIM via a reverse takeover. Trading in the ordinary shares commenced on July 4th 2014. Premaitha employs next generation DNA analysis … Continued